Targeting more than tumors: The impact of enfortumab vedotin and pembrolizumab (EV/P) on skeletal muscle loss and sarcopenia in metastatic urothelial carcinoma (mUC). This is an ASCO Meeting Abstract ...
Biparametric MRI detects prostate tumors with an accuracy similar to that of multiparametric MRI without the cost and risks associated with intravenous gadolinium contrast, a new meta-analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results